Featuring a discussion on recent data with CDK4/6 inhibitors in
adjuvant therapy for ER-positive breast cancer with Prof Stephen
Johnston, including the following topics:
Management of Localized ER-Positive, HER2-Negative Early Breast
Cancer: Recent Advances in Adjuvant Systemic Endocrine-Based
Therapies — Stephen Johnston, MA, PhD (0:00)
Case: A postmenopausal woman in her mid-50s with high-risk
ER-positive, HER2-negative breast cancer who receives abemaciclib
in addition to standard adjuvant hormonal therapy on the monarchE
trial (24:37)
Case: A woman in her mid-40s with recurrent ER-positive,
HER2-negative breast cancer and oligometastatic disease to the
bones (29:14)
Case: A premenopausal woman in her mid-40s with ER-positive,
HER2-negative breast cancer and a 21-gene assay Recurrence
Score® of 19 (33:07)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.